Denise Jurczyszak
Overview
Explore the profile of Denise Jurczyszak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
1698
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jurczyszak D, Manganaro L, Buta S, Gruber C, Martin-Fernandez M, Taft J, et al.
PLoS Pathog
. 2022 Mar;
18(3):e1010405.
PMID: 35333911
Type I interferons (IFN-Is) are a group of potent inflammatory and antiviral cytokines. They induce IFN stimulated genes (ISGs), which act as proinflammatory mediators, antiviral effectors, and negative regulators of...
2.
Krammer F, Srivastava K, Alshammary H, Amoako A, Awawda M, Beach K, et al.
N Engl J Med
. 2021 Mar;
384(14):1372-1374.
PMID: 33691060
No abstract available.
3.
Klingler J, Weiss S, Itri V, Liu X, Oguntuyo K, Stevens C, et al.
J Infect Dis
. 2020 Dec;
223(6):957-970.
PMID: 33367897
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people globally. Virus infection requires the receptor-binding domain (RBD) of the spike protein. Although studies have demonstrated anti-spike...
4.
Klingler J, Weiss S, Itri V, Liu X, Oguntuyo K, Stevens C, et al.
medRxiv
. 2020 Nov;
PMID: 33173891
Background: SARS-CoV-2 has infected millions of people globally. Virus infection requires the receptor-binding domain (RBD) of the spike protein. Although studies have demonstrated anti-spike and - RBD antibodies to be...
5.
Weiss S, Klingler J, Hioe C, Amanat F, Baine I, Arinsburg S, et al.
J Infect Dis
. 2020 Aug;
222(10):1629-1634.
PMID: 32860510
More than 24 million infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were confirmed globally by September 2020. While polymerase chain reaction-based assays are used for diagnosis, there...
6.
Weiss S, Klingler J, Hioe C, Amanat F, Baine I, Kojic E, et al.
medRxiv
. 2020 Jun;
PMID: 32511609
Background: More than one million infections with the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) have been confirmed. While PCR-based assays are used for diagnosis, high through-put serologic methods...
7.
Amanat F, Stadlbauer D, Strohmeier S, Nguyen T, Chromikova V, McMahon M, et al.
medRxiv
. 2020 Jun;
PMID: 32511441
SARS-Cov-2 (severe acute respiratory disease coronavirus 2), which causes Coronavirus Disease 2019 (COVID19) was first detected in China in late 2019 and has since then caused a global pandemic. While...
8.
Amanat F, Stadlbauer D, Strohmeier S, Nguyen T, Chromikova V, McMahon M, et al.
Nat Med
. 2020 May;
26(7):1033-1036.
PMID: 32398876
Here, we describe a serological enzyme-linked immunosorbent assay for the screening and identification of human SARS-CoV-2 seroconverters. This assay does not require the handling of infectious virus, can be adjusted...
9.
Jurczyszak D, Zhang W, Terry S, Kehrer T, Bermudez Gonzalez M, McGregor E, et al.
PLoS Pathog
. 2020 Feb;
16(2):e1008305.
PMID: 32053707
N6-methyladenosine (m6A) is the most abundant HIV RNA modification but the interplay between the m6A reader protein YTHDF3 and HIV replication is not well understood. We found that knockout of...
10.
Goody M, Jurczyszak D, Kim C, Henry C
PLoS Curr
. 2017 Dec;
9.
PMID: 29188128
Introduction: Both genetic and infectious diseases can result in skeletal muscle degeneration, inflammation, pain, and/or weakness. Duchenne muscular dystrophy (DMD) is the most common congenital muscle disease. DMD causes progressive...